These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 38791431)
1. Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity. Szyposzynska A; Bielawska-Pohl A; Paprocka M; Bar J; Murawski M; Klimczak A Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791431 [TBL] [Abstract][Full Text] [Related]
2. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens. Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422 [TBL] [Abstract][Full Text] [Related]
3. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
4. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers. Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682 [TBL] [Abstract][Full Text] [Related]
5. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines]. Song Y; Kong BH; Liu PS; Ma DX; Jiang S Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708 [TBL] [Abstract][Full Text] [Related]
6. ALDH1-high ovarian cancer stem-like cells can be isolated from serous and clear cell adenocarcinoma cells, and ALDH1 high expression is associated with poor prognosis. Kuroda T; Hirohashi Y; Torigoe T; Yasuda K; Takahashi A; Asanuma H; Morita R; Mariya T; Asano T; Mizuuchi M; Saito T; Sato N PLoS One; 2013; 8(6):e65158. PubMed ID: 23762304 [TBL] [Abstract][Full Text] [Related]
7. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer. Nunes M; Pacheco F; Coelho R; Leitão D; Ricardo S; David L Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162954 [TBL] [Abstract][Full Text] [Related]
8. Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells. Kryczek I; Liu S; Roh M; Vatan L; Szeliga W; Wei S; Banerjee M; Mao Y; Kotarski J; Wicha MS; Liu R; Zou W Int J Cancer; 2012 Jan; 130(1):29-39. PubMed ID: 21480217 [TBL] [Abstract][Full Text] [Related]
9. Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity. Bonuccelli G; Peiris-Pages M; Ozsvari B; Martinez-Outschoorn UE; Sotgia F; Lisanti MP Oncotarget; 2017 Feb; 8(6):9868-9884. PubMed ID: 28039467 [TBL] [Abstract][Full Text] [Related]
10. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells. Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703 [TBL] [Abstract][Full Text] [Related]
11. High expression of hTERT and stemness genes in BORIS/CTCFL positive cells isolated from embryonic cancer cells. Alberti L; Renaud S; Losi L; Leyvraz S; Benhattar J PLoS One; 2014; 9(10):e109921. PubMed ID: 25279549 [TBL] [Abstract][Full Text] [Related]
12. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium. Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846 [TBL] [Abstract][Full Text] [Related]
13. Side population rather than CD133(+) cells distinguishes enriched tumorigenicity in hTERT-immortalized primary prostate cancer cells. Zhou J; Wang H; Cannon V; Wolcott KM; Song H; Yates C Mol Cancer; 2011 Sep; 10():112. PubMed ID: 21917149 [TBL] [Abstract][Full Text] [Related]
14. Description of the CD133+ subpopulation of the human ovarian cancer cell line OVCAR3. Guo R; Wu Q; Liu F; Wang Y Oncol Rep; 2011 Jan; 25(1):141-6. PubMed ID: 21109969 [TBL] [Abstract][Full Text] [Related]
15. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]. Kong BH; Song Y; Ma DX; Qu X; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323 [TBL] [Abstract][Full Text] [Related]
16. Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells. Gauck D; Keil S; Niggemann B; Zänker KS; Dittmar T BMC Cancer; 2017 Aug; 17(1):515. PubMed ID: 28768501 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer. Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640 [TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell-like characteristics and telomerase activity of the nasopharyngeal carcinoma radioresistant cell line CNE-2R. Chen KH; Guo Y; Li L; Qu S; Zhao W; Lu QT; Mo QY; Yu BB; Zhou L; Lin GX; Sun YC; Zhu XD Cancer Med; 2018 Sep; 7(9):4755-4764. PubMed ID: 30105829 [TBL] [Abstract][Full Text] [Related]
19. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells. Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma. Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]